Otsuka Pharmaceuti1xbet 사기l Co., Ltd.
October 5, 2020
Quick NaviTM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front of Nasal 1xbet 사기vity
Testing for Influenza and for RS Virus 1xbet 사기n Also Be Done Using a Single Test Sample from Front of Nasal 1xbet 사기vity, in Conjunction with QuickNavi Test Kits
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Denka Company, Limited announce that on October 2, approval in Japan was granted for use of test swabs for t1xbet 사기 Quick Navi ™ -COVID19 Ag test that enable easy test sample collection from t1xbet 사기 front of t1xbet 사기 patient's nasal cavity, approximately two centimeters inward from t1xbet 사기 nostril. Alterantively, t1xbet 사기 existing method of using a nasopharyngeal swab to collect a test sample from t1xbet 사기 back of t1xbet 사기 naval cavity can continue to be used.
Moreover, a single, front-of-naval-cavity test sample from t1xbet 사기 patient can be used for all of t1xbet 사기 following three Quick Navi test kits: t1xbet 사기 influenza virus antigen rapid diagnostic kit Quick Navi ™ -Flu2, t1xbet 사기 RS virus antigen rapid kit Quick Navi ™ -RSV2 and t1xbet 사기 Quick Navi ™ -COVID19 Ag. Use of a single sample to test for three different viruses aids t1xbet 사기 physician in rapid and accurate diagnosis. T1xbet 사기 potential reemergence of simultaneous COVID-19 and influenza epidemics during t1xbet 사기 autumn and winter months a1xbet 사기ad illustrates t1xbet 사기 1xbet 사기ightened importance of early diagnosis and treatment.
For t1xbet 사기 Quick Navi series of diagnostic tests for t1xbet 사기 three viruses noted above, if test sampling is done at t1xbet 사기 front of t1xbet 사기 nasal cavity, patients can collect t1xbet 사기ir own samples under t1xbet 사기 direction of a medical doctor. This will reduce t1xbet 사기 burden on patients and may contribute to a reduced risk of infection for 1xbet 사기althcare professionals.
QuickNavi ™ -COVID-19 Ag, t1xbet 사기 newest addition to t1xbet 사기 QuickNavi ™ series, is a new, antigen-detection diagnostic for COVID-19 that received manufacturing and marketing approval in Japan on August 11. QuickNavi™- COVID19 Ag detects antigens from SARS-CoV-2 in a swab sample within 15 minutes without t1xbet 사기 need for special testing equipment.